Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLOD2 | O00469 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | BAD | Q92934 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MLYCD | O95822 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584064 | 0.83 | CES2 (0.43) | CES1CES2RAB9ACA2CA1 | |
| SCHEMBL583454 | 0.83 | CES1 (0.43) | CES1CES2CA2CA1MLYCD | |
| SCHEMBL9770781 | 0.83 | CA2 (0.55) | CES1CES2PTPN1NPC1RAB9A | |
| SCHEMBL583437 | 0.82 | CES1 (0.57) | CES1CES2PTPN1NPC1RAB9A | |
| SCHEMBL9655468 | 0.81 | CES1 (0.55) | CES1CES2PTPN1NPC1RAB9A | |
| SCHEMBL9565947 | 0.81 | CES1 (0.55) | CES1CES2PTPN1NPC1RAB9A | |
| SCHEMBL9630805 | 0.81 | CES1 (0.55) | CES1CES2PTPN1NPC1RAB9A | |
| SCHEMBL9770874 | 0.80 | ALDH1A1 (0.48) | NPC1RAB9AMLYCD | |
| SCHEMBL9770760 | 0.80 | CES1 (0.46) | CES1PTPN1NPC1RAB9A | |
| SCHEMBL2851867 | 0.79 | PLOD2 (0.51) | PLOD2LTA4HKMT2AMLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5316909-A | Quantitative analysis | WALLAC OY (FI) | 1994-05-31 | — | — | US | claimed |
| WO-1992016840-A1 | LANTHANID FLUORESCENCE ASSAY | OY DATACITY CENTER AB (FI) | 1992-10-01 | — | — | WO | claimed |
| US-4857475-A | Labelled and labellable reagents for fluorometric assays | Ekins, Roger Philip (GB) | 1989-08-15 | — | — | US | claimed |
| CN-108085490-B | Extraction composition and method for enriching lithium | 青海恒信融锂业科技有限公司 | 2020-04-28 | — | — | CN | disclosed |
| EP-3168848-B1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFICATION PRODUCT THEREOF | FUJIFILM CORP (JP) | 2019-05-22 | — | — | EP | disclosed |
| EP-3168848-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFICATION PRODUCT THEREOF | Fujifilm Corporation (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-20170117100-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF | FUJIFILM CORPORATION (JP) | 2017-04-27 | — | — | US | disclosed |
| US-9017962-B2 | Intracellular reporters | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-04-28 | — | — | US | disclosed |
| EP-1943262-B1 | IRE-1 ALPHA SUBSTRATES | MANNKIND CORP (US) | 2013-01-23 | — | — | EP | disclosed |
| EP-2504423-A1 | MULTI-PURPOSE SUBSTRATES USEFUL FOR CELL CULTURE AND METHODS FOR MAKING AND USING THE SAME | Corning Incorporated (US) | 2012-10-03 | — | — | EP | disclosed |
| US-8252549-B2 | Multi-purpose substrates useful for cell culture and methods for making | CORNING INCORPORATED (US) | 2012-08-28 | — | — | US | disclosed |
| US-20070111270-A1 | cAMP reporters and high throughput assays | THE JOHNS HOPKINS UNIVERSITY (US) | 2007-05-17 | — | — | US | disclosed |
| US-20070105123-A1 | IRE-1alpha substrates | MANNKIND CORPORATION (US) | 2007-05-10 | — | — | US | disclosed |
| US-20070020700-A1 | Lateral flow assay and device using magnetic particles | IDEXX LABORATORIES, INC. | 2007-01-25 | — | — | US | disclosed |
| US-20070020699-A1 | Lateral flow assay and device using magnetic particles | IDEXX LABORATORIES, INC. (US) | 2007-01-25 | — | — | US | disclosed |
| EP-1745143-A1 | METHODS AND TOOLS FOR DETECTING COLLAGEN DEGRADATION | Cambrex Bio Science Walkersville, Inc (US) | 2007-01-24 | — | — | EP | disclosed |
| WO-2005113794-A1 | METHODS AND TOOLS FOR DETECTING COLLAGEN DEGRADATION | CAMBREX BIO SCIENCE WALKERSVILLE, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050250171-A1 | Methods and tools for detecting collagen degradation | CAMBREX BIO SCIENCE WALKERSVILLE, INC. (US) | 2005-11-10 | — | — | US | disclosed |
| US-20010055776-A1 | High throughput cell-based assay kits | GREENWALT DALE (US) | 2001-12-27 | — | — | US | disclosed |
| US-5006254-A | Extraction with halogenated beta-diketone | RHONE-POULENC CHIMIE (FR) | 1991-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170117100-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF | DLK1, CACNA1C, CRY1 | PLOD2 755/4885CES1 1639/4885CES2 2044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.